NCT01637935View on ClinicalTrials.gov

Cohort Study of Pioglitazone and Bladder Cancer in Patients With Type II Diabetes

CompletedOBSERVATIONAL
Enrollment

193,099

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
DiabetesBladder Cancer
Interventions
DRUG

Pioglitazone

Pioglitazone tablets.

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
collaborator

Kaiser Permanente

OTHER

collaborator

Department of Epidemiology at University of Pennsylvania

UNKNOWN

lead

Takeda

INDUSTRY